Burchfield v. U.S., 98-2024

Decision Date02 March 1999
Docket NumberNo. 98-2024,98-2024
Citation168 F.3d 1252
Parties12 Fla. L. Weekly Fed. C 554 Boyd BURCHFIELD, Plaintiff-Appellant, v. UNITED STATES of America, Department of Veteran Affairs, Defendants-Appellees.
CourtU.S. Court of Appeals — Eleventh Circuit

Harry M. Hobbs, Walter O. Hobbs, Jr., Tampa, FL, for Plaintiff-Appellant.

Charles R. Wilson, U.S. Attorney, Tamra Phipps, Asst. U.S. Attorney, Susan Roark Waldron, Asst. U.S. Attorney, Tampa, FL, for Defendants-Appellees.

Appeal from the United States District Court for the Middle District of Florida.

Before HATCHETT, Chief Judge, MARCUS, Circuit Judge, and KRAVITCH, Senior Circuit Judge.

KRAVITCH, Senior Circuit Judge:

A plaintiff who sues under the Federal Tort Claims Act, 28 U.S.C. §§ 2671 et seq. ("FTCA"), must first present his or her claim to the appropriate federal agency. 28 U.S.C. § 2675(a). This case requires us to determine the amount of information that this claim must contain. Appellant Boyd Burchfield ("Burchfield") sued the United States pursuant to the FTCA, alleging that the negligence of employees of the Department of Veterans Affairs ("VA") led to his severe osteoporosis. The district court held that it lacked subject matter jurisdiction over the complaint because the claim that Burchfield had presented to the VA did not satisfy 28 U.S.C. § 2675(a). We conclude that Burchfield's claim contained sufficient information to meet the presentment requirements of section 2675(a), and therefore reverse and remand for further proceedings.

I.

While on active duty with the United States Army in 1968, Burchfield developed a tumor of the pituitary gland. Army doctors operated to remove the tumor, but it reoccurred in 1986 and Burchfield underwent five additional surgeries, the last in 1990. As a result of the surgeries, Burchfield developed panhypopituitarism (non-functioning of the pituitary gland), which caused his body to stop producing cortisone, thyroid hormone, and testosterone. To replace some of these natural hormones his doctors, VA employees, prescribed a corticosteroid, Prednisone. As far as the record before us shows, Burchfield's doctors did not accompany this prescription with a program of dietary supplements to combat osteoporosis, such as Vitamin D, calcium or calcitonin. The doctors also prescribed injectable testosterone, which can help to restore sexual function and prevent osteoporosis. After a short time Burchfield discontinued the testosterone treatments, telling his doctors that he disliked their side effects and that he was not interested in regaining sexual function. It is not clear whether Burchfield's doctors informed him that injectable testosterone treatments could help prevent osteoporosis.

Beginning as early as 1988, Burchfield developed osteoporosis, which had become severe by 1996. As a result, he suffered various injuries, including rib and sternal fractures and collapsed vertebrae, and is at risk of further injury.

Pursuant to the requirements of 28 U.S.C. § 2675(a), 1 Burchfield filed an administrative claim on Standard Form 95 with the VA on January 17, 1996. The claim stated:

Beginning August of 1990 and in subsequent years, physicians employed by the Department of Veterans Affairs prescribed a medication for Mr. Burchfield, prednisone. Mr. Burchfield's use of this medicine caused him to develop osteoporosis, resulting in severe and continuing maladies and injuries, including but not limited to the collapse or fracture of several vertebrae and ribs.... These injuries resulted from negligence of the Department's agents. 2

The claim listed thirteen doctors who had treated Burchfield. After six months, during which the VA failed to make a final disposition of the claim, Burchfield filed suit in district court. His complaint alleged, inter alia, that osteoporosis was a "known and anticipated effect[ ] of corticosteroid therapy" 3 and that his doctors were negligent in failing to initially diagnose osteoporosis, to monitor him for the condition during his treatment, and to administer a bone strengthening regimen. 4 At the bench trial, Burchfield's medical expert, Dr. Thomas Zizic, stated that prescribing the corticosteroid Prednisone did not in itself deviate from the standard of care. 5 He testified, however, that Burchfield's doctors deviated from the standard of care by treating him with Prednisone without taking certain other steps, such as performing initial baseline tests for osteoporosis and prescribing such supplements as calcium and Vitamin D to counteract the treatment's effects. 6

After Dr. Zizic testified, the district court addressed the issue of its jurisdiction under the FTCA. It found that Burchfield's administrative claim had alleged only that the VA's doctors were negligent in prescribing Prednisone, while at trial Burchfield had raised a "significant[ly] different claim[ ]" that the VA had "caus[ed] or contribut[ed] to the exacerbation of osteoporosis by failing to diagnose it properly and by failing to treat it properly." 7 On the basis of this distinction, the district court held that Burchfield had failed to meet the requirements of section 2675(a) by putting the VA on notice of his allegations, and that it therefore lacked subject matter jurisdiction over Burchfield's claim. The court entered judgment as a matter of law in favor of the United States.

II.

We review a district court's grant of judgment as a matter of law de novo. Morris v. Crow, 117 F.3d 449, 455 (11th Cir.1997).

A plaintiff bringing a claim against the United States under the FTCA must first present the claim to the appropriate federal agency and wait for the agency to finally deny it. An agency's failure to dispose of a claim within six months is deemed to be a final denial. See 28 U.S.C. § 2675(a). A district court only has jurisdiction over an FTCA action if the plaintiff has met section 2675(a)'s requirements. See Bush v. United States, 703 F.2d 491, 494 (11th Cir.1983).

To satisfy section 2675(a), a claimant must do two things: "(1) give[ ] the [appropriate] agency written notice of his or her claim sufficient to enable the agency to investigate and (2) place[ ] a value on his or her claim." Adams v. United States, 615 F.2d 284, 289 (5th Cir.), decision clarified on denial of reh'g, 622 F.2d 197 (5th Cir.1980). 8 Because Burchfield's administrative claim placed a dollar value on his alleged damages, 9 the only issue before us is whether his claim gave notice of the allegations he made at trial. We must determine whether the administrative claim's statement that Burchfield's "use of [Prednisone]" caused his injuries, along with its list of medical providers, was sufficient to put the VA on notice that Burchfield could allege negligence in matters closely related to the Prednisone prescription, such the doctors' failure to prescribe supplements to counteract the Prednisone's effects. We hold that Burchfield's administrative claim did put the VA on notice of such allegations. The legislative history of section 2675(a) and our own precedents guide our inquiry.

Congress had a dual purpose in enacting section 2675(a): to encourage prompt settlement of claims and to ensure fairness to FTCA litigants. The Senate reported that the law was intended to "provid[e] for more fair and equitable treatment of private individuals and claimants when they deal with the Government or are involved in litigation with their Government." S.Rep. No. 89-1327, at 2 (1966), reprinted in 1966 U.S.C.C.A.N. 2515, 2515-16 (quoting House report). It further stated that the administrative claim requirement, by giving agencies an opportunity to settle suits before litigation commenced, would "ease court congestion and avoid unnecessary litigation, while making it possible for the Government to expedite the fair settlement of tort claims asserted against the United States." Id. at 2, reprinted in 1966 U.S.C.C.A.N. at 2516 (quoting House report); see also McNeil v. United States, 508 U.S. 106, 111-12, 113 S.Ct. 1980, 1983, 124 L.Ed.2d 21 (1993) (stating that purpose of section 2675(a) is to give federal agencies "a fair opportunity to investigate and possibly settle ... claim[s]"); Adams, 615 F.2d at 288 (noting legislative history evidencing statute's purpose). Congress, therefore, enacted section 2675(a) not to place procedural hurdles before potential litigants, but to facilitate early disposition of claims. See, e.g., Lopez v. United States, 758 F.2d 806, 809 (1st Cir.1985) ("[I]ndividuals wishing to sue the government must comply with the details of [section 2675], but ... the law was not intended to put up a barrier of technicalities to defeat their claims.").

We keep section 2675(a)'s underlying purpose in mind when considering the amount of information it requires from a potential litigant. We have held that a claimant must give an administrative agency only enough information to allow the agency to "begin its own investigation" of the alleged events and explore the possibility of settlement. Adams, 615 F.2d at 292. We do not require the claimant to provide the agency with a preview of his or her lawsuit by reciting every possible theory of recovery, see Brown v. United States, 838 F.2d 1157, 1160-61 (11th Cir.1988), or every factual detail that might be relevant, see Adams, 615 F.2d at 291-92. In short, the amount of information required is "minimal." Id. at 289.

An administrative agency is deemed to be on notice not only of the theories of recovery stated in the claim, but of the theories of recovery that its reasonable investigation of the specific allegations of the claim should reveal. In Rise v. United States, 630 F.2d 1068 (5th Cir.1980), the plaintiff presented an administrative claim that Army physicians failed to diagnose and treat his wife's aneurysm. After bringing suit on that assertion, he amended his complaint to allege that the Army also was negligent in referring his wife to a civilian hospital and failing to...

To continue reading

Request your trial
73 cases
  • Claude v. United States, No. C00-3010-MWB (N.D. Iowa 4/12/2001)
    • United States
    • U.S. District Court — Northern District of Iowa
    • April 12, 2001
    ...however, define exactly what constitutes "sufficient information," thereby complying with 28 U.S.C. § 2675(a). In Burchfield v. United States, 168 F.3d 1252 (11th Cir. 1999), the Eleventh Circuit Court of Appeals did have occasion to examine and explain what constitutes "sufficient informat......
  • Bowling v. U.S.
    • United States
    • U.S. District Court — District of Kansas
    • September 17, 2010
    ...of recovery that its reasonable investigation of the specific allegations of the claim should reveal") (quoting Burchfield v. United States, 168 F.3d 1252, 1255 (11th Cir.1999)). 23 York v. InTrust Bank, N.A., 265 Kan. 271, 962 P.2d 405, 423 (1998) ("a conspiracy may be proven by either sho......
  • Boles v. United States
    • United States
    • U.S. District Court — Middle District of North Carolina
    • February 26, 2014
    ...factual detail that might be relevant.... In short, the amount of information required is minimal.” (quoting Burchfield v. United States, 168 F.3d 1252, 1255 (11th Cir.1999) (internal quotation marks omitted))). Boles' newly proposed claims all sound in negligence and are based on the event......
  • Ortiz-Lebron v. United States
    • United States
    • U.S. District Court — District of Puerto Rico
    • December 14, 2012
    ...to provide the agency with a preview of his or her lawsuit by reciting every possible theory of recovery." Burchfield v. United States, 168 F.3d 1252, 1255 (11th Cir. 1999) (citation omitted). The Seventh Circuit and Fifth Circuits are likewise in accord. See Murrey v. United States, 73 F.3......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT